Personal information

Other IDs

ResearcherID: N-6849-2016
Loop profile: 1441930

Activities

Collapse all

Employment (1)

Turku University Hospital: Turku, FI

2009-08-28 to present | Chief of Dept. (Dept. of Obst. & Gyn./Gyn Oncology)
Employment
Source: Self-asserted source
Sakari Hietanen

Education and qualifications (1)

University of Turku: Turku, FI

2006-03-28 to present | Adjunct professor (Dept. of Obst. & Gyn.)
Education
Source: Self-asserted source
Sakari Hietanen

Works (50 of 77)

Items per page:
Page 1 of 2

Real-life treatment patterns and time to next treatment among patients with ovarian cancer in the pre-PARP inhibitor era: the OCRWE-Finland Study

Acta Oncologica
2024-10-16 | Journal article
DOI: 10.2340/1651-226X.2024.40325
Contributors: Mari Lahelma; Heini Rauhamaa; Outi Isomeri; Juhana Idänpään-Heikkilä; Sari Käkelä; Nichola Roebuck; Barbara Mascialino; Sakari Hietanen; Mikko Loukovaara; Annika Auranen
Source: check_circle
Crossref

Deciphering cancer genomes with GenomeSpy: a grammar-based visualization toolkit

GigaScience
2024-01-02 | Journal article
DOI: 10.1093/gigascience/giae040
Contributors: Kari Lavikka; Jaana Oikkonen; Yilin Li; Taru Muranen; Giulia Micoli; Giovanni Marchi; Alexandra Lahtinen; Kaisa Huhtinen; Rainer Lehtonen; Sakari Hietanen et al.
Source: check_circle
Crossref

Circulating tumor DNA-based copy-number profiles enable monitoring treatment effects during therapy in high-grade serous carcinoma

Biomedicine & Pharmacotherapy
2023-12 | Journal article
DOI: 10.1016/j.biopha.2023.115630
Contributors: Mai T.N. Nguyen; Anna Rajavuori; Kaisa Huhtinen; Sakari Hietanen; Johanna Hynninen; Jaana Oikkonen; Sampsa Hautaniemi
Source: check_circle
Crossref

Deciphering Cancer Genomes with GenomeSpy: A Grammar-Based Visualization Toolkit

2023-10-06 | Preprint
DOI: 10.1101/2023.10.06.561159
Contributors: Kari Lavikka; Jaana Oikkonen; Yilin Li; Taru Muranen; Giulia Micoli; Giovanni Marchi; Alexandra Lahtinen; Kaisa Huhtinen; Rainer Lehtonen; Sakari Hietanen et al.
Source: check_circle
Crossref

Comorbidity of Urogynecological and Gastrointestinal Disorders in Female Patients With Lichen Sclerosus

Journal of Lower Genital Tract Disease
2023-04 | Journal article
DOI: 10.1097/lgt.0000000000000727
Part of ISSN: 1526-0976
Contributors: Jenni M. Söderlund; Niina K. Hieta; Samu H. Kurki; Katri J. Orte; Päivi Polo-Kantola; Sakari H. Hietanen; Marjut A.M. Haataja
Source: Self-asserted source
Sakari Hietanen

Efficacy and safety of maintenance olaparib and bevacizumab in ovarian cancer patients aged ≥65 years from the PAOLA-1/ENGOT-ov25 trial

European Journal of Cancer
2023-03 | Journal article | Author
DOI: 10.1016/j.ejca.2022.11.029
Part of ISSN: 0959-8049
Contributors: Renaud Sabatier; Frédérique Rousseau; Florence Joly; Claire Cropet; Coline Montégut; Johanna Frindte; Saverio Cinieri; Eva M. Guerra Alía; Stephan Polterauer; Hiroyuki Yoshida et al.
Source: Self-asserted source
Sakari Hietanen

Data from Mathematical Modeling Predicts Response to Chemotherapy and Drug Combinations in Ovarian Cancer

2023-03-31 | Preprint
DOI: 10.1158/0008-5472.c.6510459
Contributors: Emilia Kozłowska; Anniina Färkkilä; Tuulia Vallius; Olli Carpén; Jukka Kemppainen; Seija Grénman; Rainer Lehtonen; Johanna Hynninen; Sakari Hietanen; Sampsa Hautaniemi
Source: check_circle
Crossref
grade
Preferred source (of 3)‎

Supplementary material from Mathematical Modeling Predicts Response to Chemotherapy and Drug Combinations in Ovarian Cancer

2023-03-31 | Preprint
DOI: 10.1158/0008-5472.22419759
Contributors: Emilia Kozłowska; Anniina Färkkilä; Tuulia Vallius; Olli Carpén; Jukka Kemppainen; Seija Grénman; Rainer Lehtonen; Johanna Hynninen; Sakari Hietanen; Sampsa Hautaniemi
Source: check_circle
Crossref
grade
Preferred source (of 3)‎

Supplementary Table from Mathematical Modeling Predicts Response to Chemotherapy and Drug Combinations in Ovarian Cancer

2023-03-31 | Preprint
DOI: 10.1158/0008-5472.22419762.v1
Contributors: Emilia Kozłowska; Anniina Färkkilä; Tuulia Vallius; Olli Carpén; Jukka Kemppainen; Seija Grénman; Rainer Lehtonen; Johanna Hynninen; Sakari Hietanen; Sampsa Hautaniemi
Source: check_circle
Crossref
grade
Preferred source (of 3)‎

Functional Homologous Recombination Assay on FFPE Specimens of Advanced High-Grade Serous Ovarian Cancer Predicts Clinical Outcomes

Clinical Cancer Research
2023-03-09 | Journal article | Author
DOI: 10.1158/1078-0432.ccr-22-3156
Part of ISSN: 1078-0432
Part of ISSN: 1557-3265
Contributors: Sanna Pikkusaari; Manuela Tumiati; Anni Virtanen; Jaana Oikkonen; 0000-0002-3268-1969; Fernando Perez-Villatoro; Taru Annika Muranen; Matilda Salko; Kaisa Huhtinen; Anna Kanerva et al.
Source: Self-asserted source
Sakari Hietanen

Homologous Recombination Repair Gene Mutations to Predict Olaparib Plus Bevacizumab Efficacy in the First-Line Ovarian Cancer PAOLA-1/ENGOT-ov25 Trial

JCO Precision Oncology
2023-01 | Journal article
DOI: 10.1200/po.22.00258
Part of ISSN: 2473-4284
Contributors: Eric PUJADE-LAURAINE; Jessica Brown; Alan Barnicle; Jonathan Wessen; Pierre Lao-Sirieix; Steven Criscione; Andreas du Bois; Domenica Lorusso; Ignacio Romero; Edgar Petru et al.
Source: Self-asserted source
Sakari Hietanen

Optimized detection of homologous recombination deficiency improves the prediction of clinical outcomes in cancer

npj Precision Oncology
2022-12-29 | Journal article | Author
DOI: 10.1038/s41698-022-00339-8
Part of ISSN: 2397-768X
Contributors: Fernando Perez-Villatoro; Jaana Oikkonen; Julia Casado; Anastasiya Chernenko; Doga C. Gulhan; Manuela Tumiati; Yilin Li; Kari Lavikka; Sakari Hietanen; Johanna Hynninen et al.
Source: Self-asserted source
Sakari Hietanen
grade
Preferred source (of 2)‎

Efficacy of niraparib by time of surgery and postoperative residual disease status: A post hoc analysis of patients in the PRIMA/ENGOT-OV26/GOG-3012 study

Gynecologic Oncology
2022-07 | Journal article
DOI: 10.1016/j.ygyno.2022.04.012
Part of ISSN: 0090-8258
Contributors: Roisin E. O'Cearbhaill; Jose-Alejandro Pérez-Fidalgo; Bradley J. Monk; Ignacio Tusquets; Colleen McCormick; Jose Fuentes; Richard G. Moore; Christof Vulsteke; Mark S. Shahin; Frédéric Forget et al.
Source: Self-asserted source
Sakari Hietanen
grade
Preferred source (of 3)‎

QuantISH: RNA in situ hybridization image analysis framework for quantifying cell type-specific target RNA expression and variability

Laboratory Investigation
2022-07 | Journal article
DOI: 10.1038/s41374-022-00743-5
Part of ISSN: 0023-6837
Contributors: Sanaz Jamalzadeh; Antti Häkkinen; Noora Andersson; Kaisa Huhtinen; Anna Laury; Sakari Hietanen; Johanna Hynninen; Jaana Oikkonen; Olli Carpén; Anni Virtanen et al.
Source: Self-asserted source
Sakari Hietanen
grade
Preferred source (of 2)‎

Cisplatin overcomes radiotherapy resistance in OCT4-expressing head and neck squamous cell carcinoma.

Oral oncology
2022-03 | Journal article
DOI: 10.1016/j.oraloncology.2022.105772
PMID: 35245886
Contributors: Routila J; Qiao X; Weltner J; Rantala JK; Carpén T; Hagström J; Mäkitie A; Leivo I; Ruuskanen M; Söderlund J et al.
Source: Self-asserted source
Sakari Hietanen via Europe PubMed Central

Longitudinal single-cell RNA-seq analysis reveals stress-promoted chemoresistance in metastatic ovarian cancer

Science Advances
2022-02-25 | Journal article | Author
DOI: 10.1126/sciadv.abm1831
Part of ISSN: 2375-2548
Contributors: Kaiyang Zhang; Erdogan Pekcan Erkan; Sanaz Jamalzadeh; Jun Dai; Noora Andersson; Katja Kaipio; Tarja Lamminen; Naziha Mansuri; Kaisa Huhtinen; Olli Carpen et al.
Source: Self-asserted source
Sakari Hietanen
grade
Preferred source (of 2)‎

Imaging of Tumor Hypoxia With 18F-EF5 PET/MRI in Cervical Cancer.

Clinical nuclear medicine
2021-12 | Journal article
DOI: 10.1097/rlu.0000000000003914
PMID: 34619699
Contributors: Narva SI; Seppänen MP; Raiko JRH; Forsback SJ; Orte KJ; Virtanen JM; Hynninen J; Hietanen S
Source: Self-asserted source
Sakari Hietanen via Europe PubMed Central

Comorbidity of Dermal and Cardiovascular Disorders with Lichen Sclerosus: A Case-control Study.

Acta dermato-venereologica
2021-11 | Journal article
DOI: 10.2340/actadv.v101.433
PMID: 34664080
Contributors: Hieta N; Rintala M; Söderlund JM; Samu K; Orte K; Hietanen S
Source: Self-asserted source
Sakari Hietanen via Europe PubMed Central

Network-guided identification of cancer-selective combinatorial therapies in ovarian cancer

Briefings in Bioinformatics
2021-11-05 | Journal article
DOI: 10.1093/bib/bbab272
Part of ISSN: 1467-5463
Part of ISSN: 1477-4054
Contributors: Liye He; Daria Bulanova; Jaana Oikkonen; Antti Häkkinen; Kaiyang Zhang; Shuyu Zheng; Wenyu Wang; Erdogan Pekcan Erkan; Olli Carpén; Titta Joutsiniemi et al.
Source: Self-asserted source
Sakari Hietanen

PRISM: recovering cell-type-specific expression profiles from individual composite RNA-seq samples

Bioinformatics
2021-09-29 | Journal article
DOI: 10.1093/bioinformatics/btab178
Part of ISSN: 1367-4803
Part of ISSN: 1460-2059
Contributors: Antti Häkkinen; Kaiyang Zhang; Amjad Alkodsi; Noora Andersson; Erdogan Pekcan Erkan; Jun Dai; Katja Kaipio; Tarja Lamminen; Naziha Mansuri; Kaisa Huhtinen et al.
Source: Self-asserted source
Sakari Hietanen
grade
Preferred source (of 2)‎

Targeting DNA Homologous Repair Proficiency With Concomitant Topoisomerase II and c-Abl Inhibition

Frontiers in Oncology
2021-09-20 | Journal article
DOI: 10.3389/fonc.2021.733700
Part of ISSN: 2234-943X
Contributors: Arafat Siddiqui; Manuela Tumiati; Alia Joko; Jouko Sandholm; Pia Roering; Sofia Aakko; Reetta Vainionpää; Katja Kaipio; Kaisa Huhtinen; Liisa Kauppi et al.
Source: Self-asserted source
Sakari Hietanen
grade
Preferred source (of 2)‎

Optimized detection of allelic imbalances specific for homologous recombination deficiency improves the prediction of clinical outcomes in cancer

2021-08 | Preprint
DOI: 10.1101/2021.08.19.456809
PPR: PPR384781
Contributors: Perez-Villatoro F; Oikkonen J; Casado J; Chernenko A; Gulhan DC; Tumiati M; Li Y; Lavikka K; Hietanen S; Hynninen J et al.
Source: Self-asserted source
Sakari Hietanen via Europe PubMed Central

Co-evolution of matrisome and adaptive adhesion dynamics drives ovarian cancer chemoresistance

Nature Communications
2021-06-23 | Journal article
DOI: 10.1038/s41467-021-24009-8
Part of ISSN: 2041-1723
Contributors: Elina A Pietilä; Jordi Gonzalez-Molina; Lidia Moyano-Galceran; Sanaz Jamalzadeh; Kaiyang Zhang; Laura Lehtinen; S. Pauliina Turunen; Tomás A. Martins; Okan Gultekin; Tarja Lamminen et al.
Source: Self-asserted source
Sakari Hietanen

Agile workflow for interactive analysis of mass cytometry data

Bioinformatics
2021-06-09 | Journal article
DOI: 10.1093/bioinformatics/btaa946
Part of ISSN: 1367-4803
Part of ISSN: 1460-2059
Contributors: Julia Casado; Oskari Lehtonen; Ville Rantanen; Katja Kaipio; Luca Pasquini; Antti Häkkinen; Elenora Petrucci; Johanna Hynninen; Sakari Hietanen; Olli Carpén et al.
Source: Self-asserted source
Sakari Hietanen

Aggressive and recurrent ovarian cancers upregulate ephrinA5, a non-canonical effector of EphA2 signaling duality

Scientific Reports
2021-04-23 | Journal article
DOI: 10.1038/s41598-021-88382-6
Part of ISSN: 2045-2322
Contributors: Joonas Jukonen; Lidia Moyano-Galceran; Katrin Höpfner; Elina A. Pietilä; Laura Lehtinen; Kaisa Huhtinen; Erika Gucciardo; Johanna Hynninen; Sakari Hietanen; Seija Grénman et al.
Source: Self-asserted source
Sakari Hietanen

A Novel Two-Lipid Signature Is a Strong and Independent Prognostic Factor in Ovarian Cancer

Cancers
2021-04-07 | Journal article | Author
DOI: 10.3390/cancers13081764
Part of ISSN: 2072-6694
Contributors: Liina Salminen; Elena Ioana Braicu; Mitja Lääperi; Antti Jylhä; Sinikka Oksa; Sakari Hietanen; Jalid Sehouli; Hagen; Andreas du Bois; Sven Mahner et al.
Source: Self-asserted source
Sakari Hietanen
grade
Preferred source (of 3)‎

FUNGI: Fusion Gene Integration Toolset.

Bioinformatics (Oxford, England)
2021-03 | Journal article
DOI: 10.1093/bioinformatics/btab206
PMID: 33772596
PMC: PMC8504624
Contributors: Cervera A; Rausio H; Kähkönen T; Andersson N; Partel G; Rantanen V; Paciello G; Ficarra E; Hynninen J; Hietanen S et al.
Source: Self-asserted source
Sakari Hietanen via Europe PubMed Central

Molecular subtype diagnosis of endometrial carcinoma: comparison of the next-generation sequencing panel and Proactive Molecular Risk Classifier for Endometrial Cancer classifier.

Human pathology
2021-03 | Journal article
DOI: 10.1016/j.humpath.2021.02.006
PMID: 33662372
Contributors: Huvila J; Orte K; Vainio P; Mettälä T; Joutsiniemi T; Hietanen S
Source: Self-asserted source
Sakari Hietanen via Europe PubMed Central
grade
Preferred source (of 2)‎

Diagnostic efficiency of whole-body <sup>18</sup>F-FDG PET/MRI, MRI alone, and SUV and ADC values in staging of primary uterine cervical cancer.

Cancer imaging : the official publication of the International Cancer Imaging Society
2021-01 | Journal article
DOI: 10.1186/s40644-020-00372-5
PMID: 33482909
PMC: PMC7821517
Contributors: Steiner A; Narva S; Rinta-Kiikka I; Hietanen S; Hynninen J; Virtanen J
Source: Self-asserted source
Sakari Hietanen via Europe PubMed Central

qSNE: quadratic rate t-SNE optimizer with automatic parameter tuning for large datasets

Bioinformatics
2020-12-22 | Journal article
DOI: 10.1093/bioinformatics/btaa637
Part of ISSN: 1367-4803
Part of ISSN: 1460-2059
Contributors: Antti Häkkinen; Juha Koiranen; Julia Casado; Katja Kaipio; Oskari Lehtonen; Eleonora Petrucci; Johanna Hynninen; Sakari Hietanen; Olli Carpén; Luca Pasquini et al.
Source: Self-asserted source
Sakari Hietanen
grade
Preferred source (of 2)‎

HE4 in the evaluation of tumor load and prognostic stratification of high grade serous ovarian carcinoma

Acta Oncologica
2020-12-01 | Journal article
DOI: 10.1080/0284186x.2020.1827157
Part of ISSN: 0284-186X
Part of ISSN: 1651-226X
Contributors: Liina Salminen; Kamlesh Gidwani; Seija Grènman; Olli Carpén; Sakari Hietanen; Kim Pettersson; Kaisa Huhtinen; Johanna Hynninen
Source: Self-asserted source
Sakari Hietanen
grade
Preferred source (of 2)‎

The feasibility of [<sup>18</sup>F]EF5-PET/CT to image hypoxia in ovarian tumors: a clinical study.

EJNMMI research
2020-09 | Journal article
DOI: 10.1186/s13550-020-00689-z
PMID: 32910291
PMC: PMC7483702
Contributors: Laasik M; Hynninen J; Forsback S; Noponen T; Seppänen M; Hietanen S
Source: Self-asserted source
Sakari Hietanen via Europe PubMed Central
grade
Preferred source (of 2)‎

Author Correction: Virtual clinical trials identify effective combination therapies in ovarian cancer

Scientific Reports
2020-07-22 | Journal article
DOI: 10.1038/s41598-020-69092-x
Part of ISSN: 2045-2322
Contributors: Emilia Kozłowska; Tuulia Vallius; Johanna Hynninen; Sakari Hietanen; Anniina Färkkilä; Sampsa Hautaniemi
Source: Self-asserted source
Sakari Hietanen
grade
Preferred source (of 2)‎

Analysis of single-cell RNA-seq data from ovarian cancer samples before and after chemotherapy links stress-related transcriptional profile with chemotherapy resistance

2020-06 | Preprint
DOI: 10.1101/2020.06.06.138362
PPR: PPR173484
Contributors: Zhang K; Erkan EP; Dai J; Andersson N; Kaipio K; Lamminen T; Mansuri N; Huhtinen K; Carpén O; Hynninen J et al.
Source: Self-asserted source
Sakari Hietanen via Europe PubMed Central

Exploratory Analysis of CA125-MGL and –STn Glycoforms in the Differential Diagnostics of Pelvic Masses

The Journal of Applied Laboratory Medicine
2020-03-01 | Journal article
DOI: 10.1093/jalm/jfz012
Part of ISSN: 2576-9456
Part of ISSN: 2475-7241
Contributors: Liina Salminen; Nimrah Nadeem; Anne Lone Rolfsen; Anne Dørum; Teemu D Laajala; Seija Grènman; Sakari Hietanen; Taija Heinosalo; Antti Perheentupa; Matti Poutanen et al.
Source: Self-asserted source
Sakari Hietanen
grade
Preferred source (of 2)‎

Association of Vulvar Melanoma with Lichen Sclerosus

Acta dermato-venereologica
2019 | Journal article
DOI: 10.2340/00015555-3103
Source: Self-asserted source
Sakari Hietanen

Behavior of FDG-avid supradiaphragmatic lymph nodes in PET/CT throughout primary therapy in advanced serous epithelial ovarian cancer: a prospective study

Cancer imaging : the official publication of the International Cancer Imaging Society
2019 | Journal article
DOI: 10.1186/s40644-019-0215-7
Source: Self-asserted source
Sakari Hietanen

Decorin Expression in Human Vulva Carcinoma: Oncosuppressive Effect of Decorin cDNA Transduction on Carcinoma Cells

The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society
2019 | Journal article
DOI: 10.1369/0022155419845373
Source: Self-asserted source
Sakari Hietanen
grade
Preferred source (of 2)‎

A longitudinal analysis of CA125 glycoforms in the monitoring and follow up of high grade serous ovarian cancer.

Gynecologic oncology
2019-12 | Journal article
DOI: 10.1016/j.ygyno.2019.12.025
PMID: 31889528
Contributors: Salminen L; Nadeem N; Jain S; Grènman S; Carpén O; Hietanen S; Oksa S; Lamminmäki U; Pettersson K; Gidwani K et al.
Source: Self-asserted source
Sakari Hietanen via Europe PubMed Central
grade
Preferred source (of 2)‎

Olaparib plus Bevacizumab as First-Line Maintenance in Ovarian Cancer.

The New England journal of medicine
2019-12 | Journal article
DOI: 10.1056/nejmoa1911361
PMID: 31851799
Contributors: Ray-Coquard I; Pautier P; Pignata S; Pérol D; González-Martín A; Berger R; Fujiwara K; Vergote I; Colombo N; Mäenpää J et al.
Source: Self-asserted source
Sakari Hietanen via Europe PubMed Central

Open Source Infrastructure for Health Care Data Integration and Machine Learning Analyses

JCO Clinical Cancer Informatics
2019-12 | Journal article
DOI: 10.1200/cci.18.00132
Part of ISSN: 2473-4276
Contributors: Veli-Matti Isoviita; Liina Salminen; Jimmy Azar; Rainer Lehtonen; Pia Roering; Olli Carpén; Sakari Hietanen; Seija Grénman; Johanna Hynninen; Anniina Färkkilä et al.
Source: Self-asserted source
Sakari Hietanen
grade
Preferred source (of 2)‎

Prospective Longitudinal ctDNA Workflow Reveals Clinically Actionable Alterations in Ovarian Cancer

JCO Precision Oncology
2019-12 | Journal article
DOI: 10.1200/po.18.00343
Part of ISSN: 2473-4284
Contributors: Jaana Oikkonen; Kaiyang Zhang; Liina Salminen; Ingrid Schulman; Kari Lavikka; Noora Andersson; Erika Ojanperä; Sakari Hietanen; Seija Grénman; Rainer Lehtonen et al.
Source: Self-asserted source
Sakari Hietanen
grade
Preferred source (of 2)‎

Virtual clinical trials identify effective combination therapies in ovarian cancer.

Scientific reports
2019-12 | Journal article
DOI: 10.1038/s41598-019-55068-z
PMID: 31822719
PMC: PMC6904444
Contributors: Kozłowska E; Vallius T; Hynninen J; Hietanen S; Färkkilä A; Hautaniemi S
Source: Self-asserted source
Sakari Hietanen via Europe PubMed Central

Vulvar malignant pleomorphic adenoma in a patient with lichen sclerosus.

JAAD case reports
2019-10 | Journal article
DOI: 10.1016/j.jdcr.2019.09.013
PMID: 31720348
PMC: PMC6838511
Contributors: Hieta NK; Kurki SH; Rintala MA; Söderlund JM; Hietanen SH; Katri OJ
Source: Self-asserted source
Sakari Hietanen via Europe PubMed Central

Niraparib in Patients with Newly Diagnosed Advanced Ovarian Cancer.

The New England journal of medicine
2019-09 | Journal article
DOI: 10.1056/nejmoa1910962
PMID: 31562799
Contributors: González-Martín A; Pothuri B; Vergote I; DePont Christensen R; Graybill W; Mirza MR; McCormick C; Lorusso D; Hoskins P; Freyer G et al.
Source: Self-asserted source
Sakari Hietanen via Europe PubMed Central

Niraparib plus bevacizumab versus niraparib alone for platinum-sensitive recurrent ovarian cancer (NSGO-AVANOVA2/ENGOT-ov24): a randomised, phase 2, superiority trial.

The Lancet. Oncology
2019-08 | Journal article
DOI: 10.1016/s1470-2045(19)30515-7
PMID: 31474354
Contributors: Mirza MR; Åvall Lundqvist E; Birrer MJ; dePont Christensen R; Nyvang GB; Malander S; Anttila M; Werner TL; Lund B; Lindahl G et al.
Source: Self-asserted source
Sakari Hietanen via Europe PubMed Central

A Functional Homologous Recombination Assay Predicts Primary Chemotherapy Response and Long-Term Survival in Ovarian Cancer Patients

Clinical cancer research : an official journal of the American Association for Cancer Research
2018 | Journal article
DOI: 10.1158/1078-0432.ccr-17-3770
Source: Self-asserted source
Sakari Hietanen

Identifying differentially methylated sites in samples with varying tumor purity

Bioinformatics (Oxford, England)
2018 | Journal article
DOI: 10.1093/bioinformatics/bty310
DOI: 10.1101/248781
Part of ISSN: 1367-4803
Part of ISSN: 1367-4811
Source: Self-asserted source
Sakari Hietanen
grade
Preferred source (of 3)‎

Mathematical Modeling Predicts Response to Chemotherapy and Drug Combinations in Ovarian Cancer

Cancer research
2018 | Journal article
DOI: 10.1158/0008-5472.can-17-3746
Source: Self-asserted source
Sakari Hietanen
grade
Preferred source (of 2)‎

Time to go functional! Determining tumors' DNA repair capacity ex vivo

Oncotarget
2018 | Journal article
DOI: 10.18632/oncotarget.26419
Source: Self-asserted source
Sakari Hietanen
Items per page:
Page 1 of 2

Peer review (2 reviews for 2 publications/grants)

Review activity for Cells. (1)
Review activity for Targeted oncology. (1)
How many people are using ORCID?